Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 4Other hematologic neoplasm 3Myeloid 3Breast 3Other neoplasm 2Endocrine 2CNS 2NET 1Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 10163Triple Negative Breast Neoplasms 1042Neoplasms 572Ovarian Neoplasms 560Neoplasm Metastasis 513Colorectal Neoplasms 467Carcinoma, Non-Small-Cell Lung 465Prostatic Neoplasms 439Lung Neoplasms 432Pancreatic Neoplasms 312Melanoma 299Stomach Neoplasms 294Breast Neoplasms, Male 257Motor Activity 252Colonic Neoplasms 238Uterine Cervical Neoplasms 225Endometrial Neoplasms 221Head and Neck Neoplasms 217Carcinoma, Intraductal, Noninfiltrating 217Carcinoma, Renal Cell 191Squamous Cell Carcinoma of Head and Neck 179Sarcoma 175Urinary Bladder Neoplasms 159Brain Neoplasms 155Esophageal Neoplasms 154Breast Carcinoma In Situ 154Lymphedema 148Fatigue 136Carcinoma, Ovarian Epithelial 134Small Cell Lung Carcinoma 128

Interventions

glutathione pegylated liposomal doxorubicin 1Trastuzumab 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Pathologic Processes × Breast × Clear all
NCT05441943 2024-03-05

Lymphaticovenous Anastomosis as Treatment for Lymphedema

Odense University Hospital

Phase NA Active not recruiting
10 enrolled
Breast

Breast Cancer Lymphedema, Breast Diseases, Breast Neoplasms, Lymphatic Diseases, Lymphedema, Neoplasms, Pathologic Processes, Postoperative Complications, Skin Diseases

NCT01166763 2016-07-18

Modulation of Breast Cancer Risk Biomarkers by High Dose Vitamin D

University of Kansas Medical Center

Phase NA Completed
30 enrolled 10 charts
Breast

Breast Diseases, Breast Neoplasms, Hyperplasia, Neoplasms, Neoplasms by Site, Pathologic Processes

NCT01386580 2015-01-22

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

BBB-Therapeutics B.V.

Phase 1/2 Completed
84 enrolled
BreastCNSDermatologicThoracic

Brain Diseases, Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases, Glioma, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Neoplastic Processes, Nervous System Diseases, Nervous System Neoplasms, Pathologic Processes, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡